+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor



Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor



Oncology Nursing Forum 15(4): 463-469




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040833062

Download citation: RISBibTeXText

PMID: 3041383


Related references

Recombinant human granulocyte macrophage colony stimulating factor gm csf a phase i trial in neutropenic aids patients. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 403, 1989

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial. Journal of the National Cancer Institute 82(8): 697-703, 1990

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial. Onkologie 11(1): 53-55, 1988

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial. Blood 73(1): 31-37, 1989

Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors. Bulletin du Cancer 80(5): 418-430, 1993

Combination therapy with interferon alpha ifn alpha zidovudine azt and recombinant granulocyte macrophage colony stimulating factor gm csf a phase i trial in patients with aids associated kaposis sarcoma. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb513, 1990

Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 79(10): 2572-2577, 1992

Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology 10(8): 1352-1358, 1992

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial. Leukemia and Lymphoma 11(3-4): 229-238, 1993

Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil. Journal of Clinical Oncology 11(12): 2411-2416, 1993

Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice. Journal of Cellular Biochemistry 38(2): 127-136, 1988

Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Experimental Hematology 16(7): 594-602, 1988

A phase II trial of recombinant human granulocyte macrophage-colony stimulating factor recombinant human interleukin-4 used as combination therapy for subjects with hormone refractory prostate cancer. Journal of Investigative Medicine 50(2): 166A, 2002

Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. Blood 77(9): 2065-2071, 1991